Malliwah J A, Tabaqchali M, Watson J, Venables C W
Department of Surgery, Royal Victoria Infirmary, Newcastle upon Tyne.
Gut. 1996 Jun;38(6):812-5. doi: 10.1136/gut.38.6.812.
METHODS/AIMS: During 1993-1994 an audit of the outcomes of a consecutive series of peptic ulcer patients, first diagnosed endoscopically between 1972-1983, was carried out. Three hundred and thirty six patients fitting the entry criteria were identified, 46 had died in the interval, and 44 were lost to follow up, leaving 246 available for evaluation. All patients completed questionnaires on their current symptomatic state, drug treatment, and details of any operations they had undergone since their original diagnosis. In addition they were asked to indicate, on an analogue scale, their overall assessment of how their ulcer problem was affecting them at the time of the review. Where available hospital records were obtained and analysed for any further admissions and the results of any further endoscopies.
Of the 246 patients, 158 were men and 88 female. Duodenal ulcers (DU) were present in 204 and gastric ulcers (GU) in 51 (nine had both a DU and GU). Since the diagnosis 65 patients had undergone surgical treatment: 44 for poor ulcer control, nine for pyloric stenosis, nine for a perforation, one for a major gastrointestinal bleed, and two for a gastric carcinoma developing within two years of the diagnosis of a GU. The overall incidence of ulcer complications during this follow up period (excluding the carcinomas) was 7.7%. Initial medical treatment was with histamine H2 blockade in 234 patients--87.4% cimetidine (C) and 11% ranitidine (R)--with other agents in the remainder. At follow up 176 patients were still receiving medical treatment (C, 71%: R, 22%, other, 7%) including 30 who had previously undergone a definitive surgical procedure. Dyspeptic symptoms were recorded in 50.4% of the patients, abdominal pain being the commonest complaint. There was a significant relation between abdominal pain and the analogue scores provided by the patients with significantly more (p = 0.02) of those who had undergone surgical treatment recording this as a continuing problem (44.6% v 36%).
There is no evidence provided by this study that, in these patients, their ulcer disease is undergoing spontaneous remission with time.
方法/目的:在1993年至1994年期间,对1972年至1983年间首次经内镜诊断的一系列连续性消化性溃疡患者的结局进行了审计。确定了336例符合纳入标准的患者,其中46例在这期间死亡,44例失访,剩余246例可供评估。所有患者均填写了关于其当前症状状态、药物治疗以及自初次诊断以来所接受任何手术细节的问卷。此外,要求他们以模拟量表的形式指出在复查时对溃疡问题对其影响的总体评估。如有可用的医院记录,则获取并分析任何进一步的住院情况以及任何进一步内镜检查的结果。
246例患者中,男性158例,女性88例。十二指肠溃疡(DU)患者204例,胃溃疡(GU)患者51例(9例同时患有DU和GU)。自诊断以来,65例患者接受了手术治疗:44例因溃疡控制不佳,9例因幽门狭窄,9例因穿孔,1例因严重胃肠道出血,2例因在GU诊断后两年内发生胃癌。在该随访期内(不包括癌症)溃疡并发症的总体发生率为7.7%。初始药物治疗中,234例患者使用组胺H2阻滞剂——87.4%使用西咪替丁(C),11%使用雷尼替丁(R),其余患者使用其他药物。随访时,176例患者仍在接受药物治疗(C,71%;R,22%,其他,7%),其中包括30例之前接受过确定性手术的患者。50.4%的患者记录有消化不良症状,腹痛是最常见的主诉。腹痛与患者提供的模拟评分之间存在显著关系,接受手术治疗的患者中,将腹痛作为持续问题记录的比例显著更高(p = 0.02)(44.6%对36%)。
本研究未提供证据表明,在这些患者中,其溃疡疾病会随时间自发缓解。